Bridgeway Capital Management, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.73 - $10.57 $77,300 - $105,700	-10,000 Reduced 48.78%	10,500 $94,000
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $129,150 - $171,995	20,500 New	20,500 $161,000
Q2 2020 Aug 14, 2020	SELL	$6.75 - $12.89 $407,700 - $778,556	-60,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.31 - $17.81 $622,724 - $1.08 Million	60,400 New	60,400 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $1.11 Million - $1.85 Million	-60,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $307,990 - $457,140	19,000 Added 46.34%	60,000 $1.19 Million
Q1 2018 May 15, 2018	BUY	$9.22 - $12.35 $378,020 - $506,350	41,000 New	41,000 $389,000

126

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $214M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.